Insider · CIK 0001711080

Grunberg Gregory

Reports to the SEC for 2 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001711080

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-02-09	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+27.4K sh	—	—	27,400
2022-05-16	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+25K sh	—	—	25,000
2021-06-17	KALAKALA BIO, Inc.A Award	Director	AAward	+20K sh	—	—	40,000
2021-04-21	ETNB89bio, Inc.S Sale	Director, 10% Owner	SSale	−850 sh	$27.60	−$23.5K	0
2021-04-15	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+12.5K sh	—	—	12,500
2020-11-16	ETNB89bio, Inc.J Other	Director, 10% Owner	JOther	+850 sh	—	—	850
2020-11-16	ETNB89bio, Inc.J Other	Director, 10% Owner	JOther	−850K sh	—	—	1,750,877
2020-07-10	ETNB89bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+109K sh	$27.50	+$3M	2,600,877
2020-06-25	KALAKALA BIO, Inc.A Award	Director	AAward	+20K sh	—	—	20,000
2020-06-22	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+7,000 sh	—	—	7,000
2020-04-05	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+7,000 sh	—	—	7,000
2020-03-13	KALAKALA BIO, Inc.P Purchase	Director	PPurchase	+2.53M sh	$7.89	+$20M	2,534,854
2019-11-13	ETNB89bio, Inc.C Conversion	Director, 10% Owner	CConversion	+1.92M sh	—	—	2,491,787
2019-11-13	ETNB89bio, Inc. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−11.9M sh	—	—	0
2019-11-11	ETNB89bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+575K sh	$16.00	+$9.2M	575,000
2019-06-05	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+21K sh	—	—	21,000
2018-10-05	KALAKALA BIO, Inc.P Purchase	Director	PPurchase	+606K sh	$8.25	+$5M	2,877,006
2018-06-12	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13K sh	—	—	12,960
2017-07-25	KALAKALA BIO, Inc.C Conversion	Director	CConversion	+2.06M sh	—	—	2,055,946
2017-07-25	KALAKALA BIO, Inc.P Purchase	Director	PPurchase	+215K sh	$15.00	+$3.23M	2,270,946
2017-07-25	KALAKALA BIO, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−10.7M sh	—	—	0
2017-07-19	KALAKALA BIO, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13K sh	—	—	12,960

Recent filings

Accepted (ET)
Feb 134
Grunberg Gregory0000899243-23-004799
SEC(opens sec.gov)
May 184
Grunberg Gregory0000899243-22-018587
SEC(opens sec.gov)
Jun 214
Grunberg Gregory0001415889-21-003120
SEC(opens sec.gov)
Apr 234
Grunberg Gregory0000899243-21-016878
SEC(opens sec.gov)
Apr 194
Grunberg Gregory0000899243-21-016233
SEC(opens sec.gov)
Nov 184
Grunberg Gregory0000899243-20-031486
SEC(opens sec.gov)
Jul 144
Grunberg Gregory0000899243-20-019122
SEC(opens sec.gov)
Jul 144
Grunberg Gregory0000899243-20-019091
SEC(opens sec.gov)
Jun 294
Grunberg Gregory0001104659-20-078310
SEC(opens sec.gov)
Apr 74
Grunberg Gregory0000899243-20-010402
SEC(opens sec.gov)
Mar 164
Grunberg Gregory0001179110-20-003675
SEC(opens sec.gov)
Nov 134
Grunberg Gregory0000899243-19-027222
SEC(opens sec.gov)
Jun 74
Grunberg Gregory0001104659-19-034522
SEC(opens sec.gov)
Oct 94
Grunberg Gregory0001179110-18-012105
SEC(opens sec.gov)
Jun 144
Grunberg Gregory0001179110-18-008526
SEC(opens sec.gov)
Jul 264
Grunberg Gregory0001179110-17-010704
SEC(opens sec.gov)

Companies

Address

C/O KALA PHARMACEUTICALS, INC. 100 BEAVER STREET, SUITE 201

WALTHAM, MA, 02453